Andrea G. Hohmann
Affiliations: | Psychological & Brain Sciences | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
cannabinoid pharmacologyWebsite:
http://www.indiana.edu/~alldrp/members/hohmann.htmlGoogle:
"Andrea Hohmann"Mean distance: 13.89 (cluster 6) | S | N | B | C | P |
Children
Sign in to add trainee| Andrea G. Nackley | grad student | 2000-2003 | Indiana University |
| Natale R. Sciolino | grad student | 2008-2009 | University of Georgia |
| Elizabeth J. Rahn | grad student | 2005-2010 | Neuroscience and Behavior Program, University of Georgia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lin X, Xu Z, Carey L, et al. (2021) A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. Pain |
| Iyer V, Slivicki RA, Thomaz AC, et al. (2020) The cannabinoid CB receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence. European Journal of Pharmacology. 886: 173544 |
| Slivicki RA, Iyer V, Mali SS, et al. (2020) Positive Allosteric Modulation of CB Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward. Frontiers in Molecular Neuroscience. 13: 54 |
| Garai S, Kulkarni PM, Schaffer PC, et al. (2019) Application of Fluorine- And Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of CB1 Receptor Positive Allosteric Modulators. Journal of Medicinal Chemistry |
| Slivicki RA, Mali SS, Hohmann AG. (2019) Voluntary exercise reduces both chemotherapy-induced neuropathic nociception and deficits in hippocampal cellular proliferation in a mouse model of paclitaxel-induced peripheral neuropathy. Neurobiology of Pain (Cambridge, Mass.). 6: 100035 |
| Ferris CF, Nodine S, Pottala T, et al. (2019) Alterations in brain neurocircuitry following treatment with the chemotherapeutic agent paclitaxel in rats. Neurobiology of Pain (Cambridge, Mass.). 6: 100034 |
| Slivicki RA, Xu Z, Mali SS, et al. (2019) Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance, physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro. Pharmacological Research |
| Li AL, Lin X, Dhopeshwarkar AS, et al. (2018) The cannabinoid CB2 agonist AM1710 differentially suppresses distinct pathological pain states and attenuates morphine tolerance and withdrawal. Molecular Pharmacology |
| Slivicki RA, Saberi SA, Iyer V, et al. (2018) Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit. The Journal of Pharmacology and Experimental Therapeutics |
| Liu Y, Ji L, Eno M, et al. (2018) (R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes. Journal of Medicinal Chemistry |